Groowe Groowe / Newsroom / BIOA
⏱ News is delayed by 15 minutes. Sign in for real-time access. Sign in

BIOA News

BioAge Labs, Inc. Common Stock

Global Drug Discovery Technology Market Analysis and Forecast 2026-2030 | AI, Precision Medicine, and Digital Biology Drive USD 31.56 Billion Growth at 9.1% CAGR

globenewswire.com
AGNT BDX BIOA BRKR GLW DHR GSBC ILMN MRK RVTY TMO

Deep Origin Announces Multi-Target AI-Driven Drug Discovery Collaboration with BioAge Labs; Validated Hits Confirmed against First Target

globenewswire.com
BIOA

Form 8-K

sec.gov
BIOA

BioAge Labs to Present at Upcoming Investor Conferences

globenewswire.com
BIOA BTAI

BioAge Labs Announces First Participant Dosed in QUELL-DME, a Phase 2 Trial of BGE-102, a Novel Oral NLRP3 Inhibitor, in Diabetic Macular Edema

globenewswire.com
BIOA

BioAge Labs to Present at Upcoming Investor Conferences

globenewswire.com
BIOA BTAI

Number of shares and votes in BioArctic AB (publ) as of August 31, 2026

prnewswire.com
BIOA

Form 8-K

sec.gov
BIOA

BioAge Labs Reports Second Quarter 2026 Financial Results and Provides Business Updates

globenewswire.com
BIOA

Sales of Leqembi® totaled 29.3 billion yen in the second quarter 2026

prnewswire.com
BIOA BIIB